Oertzenweg 19 b
14163 Berlin
+49 30 838 62299 / 62300
pferdeklinik@vetmed.fu-berlin.de
Background and objectives:
Antimicrobial susceptibility testing (AST) with an automated testing system (AS1) and broth microdilution (BMD1) showed differing results regarding sulfamethoxazole-trimethoprim (SXT) for Staphylococcus aureus. These findings were further investigated.
Material and methods:
S. aureus isolates (n=19) from horses revealed differing SXT susceptibility results. Therefore, a second AS (AS2) and further CLSI approved methods were tested: two BMD tests, including a commercial plate (BMD2), an inhouse set-up (BMD3) for sulfisoxazole (SUL) and trimethoprim (TMP) separately, and disk diffusion (DD) for SXT, SUL and TMP. Respective resistance geneswere deduced fromwhole genome sequences.
Results:
AS1 identified all isolates as SXT-resistant, whereas the BMD1 classified only threeisolates as resistant and 16 as susceptible. AS2 classified 17 as resistant and two as susceptible and BMD2 classified all but one as resistant. DD identified three as SXT-resistant, eleven asSXT-intermediate andfive as SXT-susceptible. For SUL, BMD3 classified 16 as susceptible and three as resistant, whereas in DD all were susceptible. In BMD3 and DD,all isolates were TMP-resistant. All isolates harbored a TMP resistance gene (dfrG [n=3] or dfrS1 [n=16]).
Conclusion:
SXT is used in human and veterinary medicine.Therefore, a correct classification of the AST results of bacterial pathogens is important, keeping in mind that different methods can reveal different results.